The Klein Law Firm Reminds Investors of Class Actions

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
80
The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Molina Healthcare, Inc., Esperion Therapeutics, Inc., Kulicke and Soffa Industries, Inc., and PPG Industries, Inc.

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Molina Healthcare, Inc. (NYSE: MOH ) Lead Plaintiff Deadline: June 29, 2018 Class Period: October 31, 2014 - August 2, 2017

Allegations: Molina Healthcare made materially false and/or misleading statements or failed to disclose that: Molina's administrative infrastructure was never designed to handle the size and complexity of its rapid growth strategy; and (2) it failed to remediate systemic issues and costly disruptions with critical administrative infrastructure functions, including provider payment and utilization management.

Get additional information: http://www.kleinstocklaw.com/pslra-c/molina-h...c-2?wire=3 .

Esperion Therapeutics, Inc. (NASDAQ: ESPR ) Lead Plaintiff Deadline: July 6, 2018 Class Period: February 22, 2017 - May 1, 2018

Allegations: Esperion’s cholesterol-lowering medication, bempedoic acid, entailed serious undisclosed safety risks, including death; and as a result of the foregoing, Esperion’s public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/esperion...c-2?wire=3 .

Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC ) Lead Plaintiff Deadline: July 10, 2018 Class Period: November 16, 2017 - May 10, 2018

Allegations: Kulicke and Soffa Industries, Inc.’s consolidated financial statements for the fiscal year ending September 30, 2017 could no longer be relied upon due to misstated warranty accruals; and as a result, Defendants' public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/kulicke-...c-2?wire=3 .

PPG Industries, Inc. (NYSE: PPG ) Lead Plaintiff Deadline: July 19, 2018 Class Period: April 24, 2017 - May 10, 2018

Allegations: PPG’s consolidated financial statements for the year ended December 31, 2017 and quarterly financial statements for 2017 contained improper accounting entries and could not be relied upon; PPG failed to maintain adequate internal controls; and as a result, defendants’ public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/ppg-indu...c-2?wire=3 .

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.                                                              Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 jk@kleinstocklaw.com   Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading